New Opportunities to Address Opioid Use Disorder

Members & Publications


June 26, 2018

New Funding Opportunity for Research on Opioid Use Disorder Among People with Disabilities

The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) at the Administration for Community Living (ACL) has announced a new funding opportunity for a Disability and Rehabilitation Research Projects (DRRP) Program: Research on Opioid Use Disorder Among People with Disabilities.

The purpose of the DRRP program is to plan and conduct research, demonstration projects, training, and related activities (including international activities) to develop methods, procedures, and rehabilitation technology that maximize the full inclusion and integration into society, employment, independent living, family support, and economic and social self-sufficiency of individuals with disabilities.

This DRRP will fund two projects, each three years in length, for conducting research on opioid use disorder among people with disabilities. Topics of interest include: systematic review of existing literature on opioid use disorder and people with disabilities; prevalence estimates and patterns of opioid use disorder; factors associated with increased risk of opioid use disorder; and effects of government policies and programs to access treatment for people with disabilities who have opioid use disorders. Click here to view more details and access application instructions.

This grant opportunity closes on July 23, 2018.

New Alternative Payment Model (APM) for Patient-Centered Opioid Addiction Treatment (P-Coat)

The American Medical Association (AMA) and the American Society of Addiction Medicine (ASAM) announced the release of a concept paper detailing an alternative payment model (APM), known as Patient-Centered Opioid Addiction Treatment (P-COAT). This APM seeks to increase utilization of and access to medications for the treatment of opioid use disorder by providing the appropriate financial support to successfully treat patients and broaden the coordinated delivery of medical, psychological, and social support services.

P-COAT is also designed to support office-based opioid treatment in order to facilitate coordination between multiple treatment providers. Previously, payment for these services has been segregated, which contributes to patient difficulties receiving comprehensive care. More information about the P-COAT APM can be found in ASAM’s issue brief here. The complete P-COAT APM can be found here.

ASAM and the AMA are seeking physician practices and insurers interested in pilot testing the new payment model. Those interested in participating in P-COAT should submit their contact information here.

Visit the Pain Management page to view the updated Position Statement on Opioid Prescribing and learn more about Academy efforts in this area.

Legislation Introduced to Alleviate Impact of Conversion Factor Cut for 2021

Nov 09, 2020

Last month, two bills were introduced in the House proposing solutions to the estimated 10.6% Physician Fee Schedule conversion factor cut expected to go into effect January 1, 2021.  The bills offer some relief to the cut, but do not reflect a comprehensive or long-term solution.  AAPM&R has therefore chosen to remain neutral regarding these bills. 

Your Academy continues to advocate for a permanent solution to the conversion factor cut while maintaining the important payment increases to office and outpatient evaluation and management services.